Dermatology Times E-News :
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
Dermatology Times E-News
Modern Medicine Network
TOP SEARCHES: Skin cancer // Hyaluronic acid fillers // Eczema
In this issue
Glaxo to promote Enbrel
Toilet-seat dermatitis returns
Agencies head to Haiti
Syneron, Candela merge
Key Topic Updates

Contact Us
Click here to contact a Dermatology Times editor.

Click here to contact a Dermatology Times sales representative.

Click here to learn about direct mail, reprints and classifieds in Dermatology Times.

Follow us on Twitter

FEBRUARY 4, 2010
Confirm your subscription click here.
In order to ensure future delivery of email newsletters from Dermatology Times please take a moment to confirm your subscription by clicking here.

Thank you,
Dermatology Times Staff

Glaxo’s Stiefel unit to promote Amgen’s Enbrel in U.S.
London — The Stiefel unit of GlaxoSmithKline, based here, will promote Amgen’s Enbrel (etanercept) psoriasis treatment to U.S. dermatologists, Bloomberg News reports. More...

Study: Toilet-seat dermatitis often misdiagnosed
Baltimore — Toilet-seat contact dermatitis is once again afflicting American children — and the rare condition is often misdiagnosed, causing delay in proper treatment, news source MedPage Today reports. More...
Hundreds of agencies respond in wake of Haiti quake
Washington — The Pan American Health Organization (PAHO) reports that more than 600 organizations and institutions are working with local Haitian authorities to bring relief to victims of the recent earthquake, Medscape Medical News reports. More...
Syneron, Candela announce merger finalization
Wayland, Mass. — Officials of aesthetic-device makers Syneron Medical of Israel and Candela, based here, have announced the successful closing of their merger, according to PR-inside.com. More...
Find the magic in Miami!
Are you headed for Miami in March? Check out our online City Guide for the best in dining, sights to see, shopping and nightlife, plus handy information on how to get around. More...
Key Topic Updates
Liability & Risk Management
Use caution when altering medical records
HITECH ratchets up HIPAA accountability
Oncology
Skin cancer checks needed for patients on voriconazole
Extended interferon not beneficial in melanoma
Psoriasis
Association between psoriasis, metabolic syndrome is strong
Study shows etanercept improves depression, anxiety
Career Opportunities

Griffin Hospital
BC/BE Dermatologist-Southern Connecticut

Dermatology Associates of Lancaster
BC/BE Dermatologist
Dermatology Associates of Spokane
BC/BE Dermatologist
Paulding Dermatology
BC/BE Dermatologist-Georgia
Watson Clinic, LLP
Dermatopathology Opportunity in Florida
Huntington Dermatology and Cosmetic Associates, PC
Dermatologist-Long Island, NY

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.